Cardinal health reports first quarter fiscal 2023 results

Revenue increased 13% to $49.6 billion gaap 1 operating earnings were $137 million, gaap diluted eps were $0.40 non-gaap operating earnings decreased 20% to $423 million due to a decline in medical segment profit, partially offset by an increase in pharmaceutical segment profit; non-gaap diluted eps decreased 7% to $1.20 company reaffirmed fiscal year 2023 non-gaap eps guidance dublin, ohio , nov. 4, 2022 /prnewswire/ -- cardinal health (nyse: cah) today reported first quarter fiscal year 2023 revenues of $49.6 billion, an increase of 13% from the first quarter of last year. first quarter gaap operating earnings were $137 million, including a non-cash, pre-tax goodwill impairment charge of $154 million in the medical segment.
CAH Ratings Summary
CAH Quant Ranking